Chabiotech Co.,Ltd. (KOSDAQ:085660)
15,100
+210 (1.41%)
Jan 19, 2026, 3:30 PM KST
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 1.2 trillion as of January 16, 2026. Its market cap has increased by 34.98% in one year.
Market Cap
1.20T
Enterprise Value
2.13T
Revenue
1.20T
Ranking
n/a
PE Ratio
n/a
Stock Price
15,100.00
Market Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 1.20T, an increase of 258.61%. That is a compound annual growth rate of 7.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.17T | 4.86% |
| Dec 30, 2025 | 1.12T | 74.51% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1.10T | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1.12T | 6.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 88.92T |
| Celltrion | 45.18T |
| ALTEOGEN | 26.53T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.26T |
| Yuhan | 7.91T |
| HLB Co., Ltd. | 6.83T |
| Sam Chun Dang Pharm. | 6.43T |